Cannabis Laws in Alabama

Adult-Use (Recreational) Cannabis

Illegal and Prohibited: Recreational (adult-use) cannabis remains illegal in Alabama. Marijuana is classified as a Schedule I controlled substance under state law, and possession or sale for non-medical purposes is criminalized^[1][1]. There is no allowance for personal recreational use—any possession outside the medical program is unlawful. Law enforcement and courts continue to treat marijuana like other controlled substances, with serious penalties for even small amounts (as detailed below under Penalties). Alabama has not decriminalized marijuana at the state level; an adult without a medical cannabis card found with cannabis can be prosecuted for a misdemeanor or felony depending on the circumstances^[1][1]. Proposals to legalize or decriminalize recreational use have repeatedly failed in the Alabama Legislature (for example, a 2022 bill to make possession under 2 ounces a fine-only violation was indefinitely postponed)^[2][2].

Hemp and CBD: Alabama does permit hemp-derived CBD products with negligible THC. Low-THC CBD oil (≤0.3% THC) has been legal since the federal 2018 Farm Bill and earlier state measures (e.g. Carly’s Law (2014) and Leni’s Law(2016) legalized possession of CBD oil for certain medical conditions)^[2]. However, the state has recently moved to tightly regulate Delta-8, Delta-10, and other hemp-derived THC products. In 2023, Alabama enacted HB 445 (effective 2025) which imposes strict controls on consumable hemp products. This law places hemp-derived cannabinoids under the Alabama Alcoholic Beverage Control (ABC) Board’s oversight and bans smokable or vapable hemp products and synthetic cannabinoids, allowing only oral edibles and beverages with ≤10 mg THC per serving^[3]. Retailers of hemp THC must be licensed by ABC, verify buyers are 21+, use child-resistant packaging, avoid marketing appealing to minors, and submit products for lab testing^[3][3]. A 10% excise tax on hemp THC product sales was established to fund state and local governments^[3]. These measures underscore that Alabama maintains a strict stance against psychoactive cannabis outside its limited medical program.

Medical Cannabis

Legal for Qualified Patients: Medical cannabis is legal in Alabama in a limited, highly regulated form. In 2021, Alabama passed the Darren Wesley “Ato” Hall Compassion Act (Senate Bill 46), now codified at Code of Alabama Title 20, Chapter 2A, which created a statewide medical cannabis program^[1]. This law allows patients with specific qualifying medical conditions (see the list below) to obtain and use cannabis-derived products for therapeutic purposes. The law also established the Alabama Medical Cannabis Commission (AMCC) to regulate licensing and oversight of medical cannabis from cultivation to sale^[1].

No Traditional Marijuana “Flower”: Notably, Alabama’s medical law does not permit smoking or raw plant material. Approved medical cannabis is limited to certain formulations (e.g. tablets, capsules, liquids) and must be obtained from licensed dispensaries. Possession and use of marijuana remain illegal for anyone not enrolled in the medical program^[1]. Even for qualified patients, only state-sanctioned products are lawful – any cannabis obtained outside the regulated system or used for non-medical purposes is prohibited^[4]. In short, Alabama’s cannabis legalization is narrowly confined to medical use under strict controls, and all other cannabis use continues to be unlawful.

Individual Consumer Laws

This section outlines Alabama laws for individuals possessing or using cannabis, including patients and the general public.

Possession Limits and Personal Use

For medical patients: A registered patient (age ≥19) or their registered caregiver may possess up to 70 daily doses of medical cannabis (roughly a 70-day supply) with a valid state-issued medical cannabis card^[5]. The “daily dose” is determined by the recommending physician and AMCC rules (physicians specify an appropriate daily dosage in the patient certification)^[6]. Possession within this limit and in conformity with program regulations is lawful for the cardholder. Patients and caregivers in compliance are explicitly protected from arrest or prosecution for possessing the allowed amount of medical cannabis^[5]. However, possessing more than 70 daily doses or any cannabis obtained from unauthorized sources is not protected and could result in criminal charges.

For non-patients: Possession of any amount of marijuana outside the medical program is a crime. Alabama distinguishes two degrees of unlawful possession of marijuana:

• Second-Degree Possession (Personal Use): Possession of marijuana for personal use (with no intent to distribute) is a Class A misdemeanor^[1]. This is the highest level misdemeanor, punishable by up to 1 year in jail and a fine up to $6,000^[1]. First-time simple possession typically falls in this category.
• First-Degree Possession: This is charged in two scenarios^[1]: (1) possession of marijuana for a purpose other than personal use (e.g. evidence of intent to sell, or a larger amount unsuitable for only personal use), or (2) any personal-use possession after a previous conviction for marijuana possession. First-degree possession is a felony (Class C felony for non-personal-use, or Class D for a repeat personal-use offense)^[1]. It carries significantly higher penalties – up to 10 years in prison and up to a $15,000 fine for a Class C felony^[1](Class D felonies in Alabama have lower sentencing ranges but are still punishable by incarceration).

In practice, a small amount for a first offender is a misdemeanor, while repeat offenders or those possessing large quantities face felonies. There is currently no general “decriminalization” threshold in Alabama – even a single gram can lead to arrest, though prosecutors have discretion. (A 2022 proposal to make <2 ounces a non-jailable violation did not become law^[2][2].)

Age Requirements

Medical use is limited to adults 19 years or older (19 is the age of majority in Alabama)^[4]. Only patients 19+ can directly obtain a medical cannabis card and purchase products. Minors under 19 cannot independently be qualified patients; however, a minor with a qualifying condition can enroll in the program through a parent or legal guardian serving as their registered caregiver^[4]. In such cases, the minor’s caregiver must be the one to purchase, possess, and administer the medical cannabis on the minor’s behalf^[4]. All registered patients (or their caregivers) must show proof of Alabama residency and have a physician’s certification for an approved condition.

For non-medical situations, age is largely irrelevant because all recreational possession/use is illegal for everyone. An adult (21 or any age) has no lawful right to use cannabis outside the medical program. If an underage person (minor) is found in possession, they can face delinquency proceedings or criminal charges similar to adults, and additional penalties may apply (e.g. distribution to a minor or involving a minor in a drug offense is treated especially severely, as noted below)^[1].

Permissible Consumption and Product Forms

Public Use: Alabama forbids the use of cannabis in public places. The medical law does not allow consumption of medical cannabis in public or in workplaces, school grounds, or correctional facilities. Patients are expected to use their medicine in private. There are also DUI laws unchanged by the medical cannabis act – driving under the influence of cannabis remains illegal, and patients can be prosecuted for impaired driving just as any other person would be.

Approved Forms for Medical Cannabis: Alabama tightly controls the forms of cannabis that patients may consume. The statute defines “medical cannabis” to include only certain preparations of cannabis derivatives^[7][7]. By law, allowed forms include:

• Oral medications: e.g. tablets, capsules, and tinctures^[7]
• Topical formulations: gels, creams, or oils for topical use^[7]
• Suppositories^[7]
• Transdermal patches^[7]
• Nebulized or inhaler oil: a liquid or oil that can be used with an inhaler (similar to an asthma inhaler)^[7]
• Non-sugar edibles: gelatinous cubes or lozenges (in defined shapes like cubes or rectangular cuboids) are permitted, but notably only if they are not sugar-coated^[7].

Crucially, the law prohibits any raw plant material and any product intended for smoking or vaping, as well as conventional food products infused with cannabis (no brownies, candies, gummies, etc.)^[7]. Thus, smokable flower, pre-rolled joints, vape oils/cartridges, and conventional sugary edibles are all prohibited, even for medical patients^[7]. The one edible-style format the law does permit is a non-sugar-coated gelatinous cube/lozenge — which the first Alabama products bring to market as a peach-flavored “gummy” (peach is the only flavor offered at launch), alongside tablets, tinctures, oils, and transdermal patches^[8]. The intent is to limit dosing to pharmaceutical-style products. Patients may only consume their medicine in these allowed forms. Any other method of ingestion (e.g. smoking a joint or using a standard cannabis edible) is not protected by the medical law and would be considered unlawful.

Home Cultivation

No Home Grow Allowed: Alabama law prohibits personal cultivation of cannabis. There is no provision for patients or anyone to grow their own marijuana plants for any purpose. All production of medical cannabis must be done by state-licensed cultivators and processors under strict regulations. If an individual were to grow cannabis, it would be treated as illegal manufacturing of a controlled substance. Cultivating even one marijuana plant is a criminal offense and, depending on circumstances, can be charged as felony possession or distribution. Larger-scale growing would likely fall under Alabama’s drug trafficking laws or “unlawful manufacture of a controlled substance” statutes, which carry severe felony penalties. For example, Alabama’s trafficking statute encompasses producing cannabis and imposes mandatory minimum prison terms based on the total weight of cannabis involved^[1]. There is no exception in these laws for personal or medical cultivation. In short, all cultivation is reserved for licensed businesses – patients must obtain medical cannabis from dispensaries only.

Penalties for Violations

Alabama imposes strict penalties for cannabis-related offenses, with severity escalating for repeat offenses, intent to distribute, or large quantities. Below is a summary of key offenses and their penalties under Alabama law (non-exhaustive):

• Possession of Marijuana (Second Degree) – Possession for personal use (first offense): Class A misdemeanor, up to 1 year in jail and $6,000 fine^[1]. (Note: While jail is possible, some first-time offenders may receive probation; however, the charge remains a serious misdemeanor on one’s record.)
• Possession of Marijuana (First Degree) – Possession for other than personal use or personal-use possession with a prior conviction: Class C or D felony. Punishable by 1–10 years in prison (up to 10 years for Class C) and up to $15,000 fine^[1]. A Class D (for repeat personal use) carries up to 5 years. First-degree possession is a felony charge that applies to intent to distribute or second/subsequent offenses.
• Unlawful Distribution / Sale of Cannabis – Selling, furnishing, or delivering any amount of marijuana is a Class B felony. Penalties range from 2 to 20 years imprisonment and up to $30,000 fine^[1]. Even sharing a small amount of marijuana without remuneration can be prosecuted as distribution under Alabama law.
• Sale to a Minor – If an adult (over 18) sells, gives, or distributes cannabis to a minor, it is a Class A felony^[1]. This is the most serious felony class, with penalties of 10 years to life in prison and up to $60,000 fine^[1]. Alabama fiercely punishes those involving minors in drug offenses.
• Enhanced Penalty – Proximity to School – Alabama law provides an enhancement if cannabis is sold (or distributed) within 3 miles of a school or college campus. An additional 5-year prison term is imposed (with no probation) on top of the underlying sentence^[1].
• Trafficking in Cannabis – Possession, transport, cultivation, or sale of large quantities is charged as drug trafficking, a Class A felony. Mandatory minimum sentences apply, based on weight: e.g., having ≥2.2 lbs (1 kilogram) up to 100 lbs carries 3 years minimum prison and $25,000 fine; 100–500 lbs carries 5-year minimumand $50,000 fine; 500–1,000 lbs has 15-year minimum and $200,000 fine; and 1,000+ lbs leads to life imprisonment without parole^[1][1]. These harsh penalties target large-scale operations. Additionally, Alabama’s Drug Trafficking Enterprise statute penalizes organizers of multi-person trafficking rings with even higher penalties (minimum 25 years and fines up to $500,000 for a first conviction)^[1].
• Paraphernalia – Possession of drug paraphernalia (pipes, bongs, scales, etc. associated with cannabis use) is a separate misdemeanor offense in Alabama, punishable by up to 1 year jail and $6,000 fine for a first offense (Class A misdemeanor). Subsequent paraphernalia convictions become Class C felonies.
• Driving Under the Influence – Driving while impaired by cannabis is treated under Alabama’s DUI laws (similar to alcohol DUIs). Convictions can lead to fines, license suspension, and possible jail time, depending on the offense number and severity.
• Miscellaneous: Using a false medical cannabis card or diverting medical cannabis to unauthorized persons is illegal. The Compassion Act contains criminal provisions for fraud or diversion, enforceable by felony or misdemeanor charges depending on the act (e.g., misrepresenting oneself to obtain a card, or caregivers misusing their status).

Civil and Employment Consequences: Cannabis convictions can carry collateral consequences, including driver’s license suspension (commonly 6 months for a drug conviction in Alabama, even for possession), difficulties with employment and housing, and ineligibility for some federal benefits. Notably, Alabama law does not require employers to accommodate medical cannabis use – employers may still enforce drug-free workplace policies and fire or refuse to hire a person who tests positive for marijuana, even if they are a registered patient. The medical law explicitly does not protect employees from adverse employment action for cannabis (and it does not permit use on the job or on employer premises). Additionally, being a registered patient does not shield one from all legal peril – for instance, cannabis remains illegal under federal law, and there are restrictions on firearm ownership for unlawful users of controlled substances (which under federal law can include state-legal marijuana users). Patients in Alabama must navigate these risks accordingly.

Alabama Medical Cannabis Program

Alabama’s medical cannabis program is established by the Compassion Act (Ala. Code § 20-2A-1 et seq.), with detailed regulations by the Alabama Medical Cannabis Commission (AMCC) and related agencies. The following covers the structure and key elements of the program, including who qualifies, how patients participate, what products are available, and how dispensaries operate.

Qualifying Medical Conditions

To become a registered patient, an individual must be diagnosed with at least one of the qualifying medical conditionsspecified by Alabama law. The conditions were written into the statute and are relatively extensive (though not as broad as some states). According to Ala. Code § 20-2A-3(21), qualifying medical conditions include^[7][7]:

• Autism Spectrum Disorder (ASD)
• Cancer-related cachexia (wasting), nausea or vomiting, weight loss, or chronic pain
• Crohn’s disease
• Depression
• Epilepsy or any condition causing seizures
• HIV/AIDS-related nausea or weight loss
• Panic disorder
• Parkinson’s disease
• Persistent nausea that is unresponsive to traditional treatment (excluding pregnancy-related nausea and excluding conditions like cannabinoid hyperemesis)^[7]
• Post-Traumatic Stress Disorder (PTSD)
• Sickle Cell anemia
• Spasticity associated with certain diseases: e.g. Amyotrophic Lateral Sclerosis (ALS) or other motor neuron diseases^[7]; Multiple Sclerosis (MS) or spinal cord injury^[7]
• Terminal illness (end-of-life or advanced illnesses with life expectancy < 6 months)
• Tourette’s syndrome
• Chronic or intractable pain (either pain that is not effectively treated by traditional methods/opioids, or where use of opioids is contraindicated)^[7].

Importantly, the law generally requires that conventional treatments have failed for these conditions (or that current standard of care supports cannabis use) before medical cannabis is recommended^[7][7]. In other words, a physician must document that standard therapies were inadequate or not appropriate for the patient’s condition, ensuring that cannabis is a treatment of last resort in many cases.

The Commission has authority to approve additional conditions via rules, but as of 2025 the above list from the statute defines the eligible conditions. Common ailments like general anxiety or ordinary chronic insomnia are not on the list. Each patient must have one of the listed diagnoses (properly documented in their medical records) to qualify for certification.

Patient Registration and Access to Medicine

Physician Certification: To join the program, a patient with a qualifying condition must obtain a recommendation (certification) from a physician who is registered with the Alabama Board of Medical Examiners (ALBME) as a certifying physician. Alabama requires doctors to undergo training and permitting to recommend cannabis: physicians must take a 4-hour medical cannabis course, pass an exam, and obtain a special Medical Cannabis Certification Permitfrom ALBME^[2]. Doctors also cannot have financial ties to cannabis businesses or refer patients to specific dispensaries^[2]. Only doctors with this permit can issue the required written certification for a patient.

Patient Registry and Card: Once a patient has a physician’s certification, they apply to the AMCC for inclusion in the Alabama Medical Cannabis Patient Registry. This involves providing personal information, the physician’s certification, and any caregiver designation if applicable. Upon approval, the patient is added to the secure state registry and issued a medical cannabis card (ID card)^[2]. The card enables the patient to purchase medical cannabis from licensed dispensaries. Caregivers (for minors or adults unable to purchase themselves) likewise register and receive a caregiver card linked to their patient^[4]. A registered caregiver may serve a maximum of two patients (or up to three if two are immediate family) per the Act. Both patients and caregivers must be Alabama residents^[9] and at least 19 years old (caregivers for minors must be the parent or guardian). The card must be renewed periodically (likely annually).

Patient Rights and Protections: Registered qualified patients and their caregivers are protected from state criminal liability for certain activities. Specifically, a cardholder age 19+ may possess and use medical cannabis within the program limits without fear of arrest or prosecution for marijuana possession^[5]. (As noted, this protection is conditional on not exceeding the allowable amount – currently 70 daily doses – and having a valid card on hand^[5].) Caregivers have similar immunity when possessing or administering cannabis on behalf of their patient. Additionally, the law provides immunity from criminal or civil penalties to licensed medical cannabis businesses and their employees for actions in compliance with the program (e.g., a dispensary employee dispensing to a cardholder is not to be prosecuted for drug distribution)^[5]. Physicians who certify patients in good faith and according to the law are also shielded from criminal liability or professional sanction for their cannabis recommendations^[5].

However, the law stops short of some protections seen in other states. For example, Alabama’s medical cannabis statute does not require employers, landlords, or any private entity to accommodate a patient’s cannabis use. It explicitly does not alter DUI laws or allow patients to drive under the influence. It also does not protect patients from federal law (which still prohibits marijuana). Thus, patients have a legal defense for possession and use under state law, but not an absolute right to use cannabis anywhere or to violate other laws. Medical cannabis must be used in private and kept securely. Diversion of medical cannabis to any non-patient is a crime; patients or caregivers caught distributing their medicine will lose program privileges and face prosecution^[4].

Medical Cannabis Products and Dosage

Alabama restricts medical cannabis to the non-smokable products enumerated in the statute (see “Permissible Forms” above). The AMCC has further refined product regulations via rules. Key points include:

• Allowed Products: Tablets, capsules, tinctures, gelatinous cubes/lozenges, transdermal patches, suppositories, gels/oils/creams, nebulized preparations, and inhaler oils are permitted^[7][7]. These must be formulated such that dosing is precise. For example, tinctures will have a known mg of cannabinoid per mL, tablets a known milligram content, etc. The Commission may approve new delivery methods fitting the law’s criteria, but smoking and edibles remain off-limits.
• Prohibited Products: Raw plant material (flower/bud), any product intended for smoking or vaping, and any edible food product infused with cannabis (like baked goods or candies) are forbidden^[7]. Sugar-coated gummies or brightly colored edibles are disallowed to prevent appeal to children. Vaporization (even of oils) is not allowed; only metered-dose inhalers (like aerosol devices) are permitted for pulmonary administration.
• Dosage and THC Limits: Alabama’s law tasks physicians with recommending a daily dosage and type of product for each patient^[6]. The daily dose is recorded in the patient registry and effectively serves as a cap on how much a patient can purchase/possess over time. By law, a single dose of medical cannabis cannot exceed 50 milligrams of THC (unless a higher amount is justified by the certifying physician for that patient)^[2]. There is also a statutory maximum on THC content in any one dose form: for example, any unit (pill, patch, etc.) cannot have more than 75 mg THC even if divided doses are recommended (the Commission’s rules might adjust specific limits). For chronic pain patients, initial dosing is limited (e.g., no more than 50mg per day for the first 90 days unless exceptions apply) to ensure cautious titration. These provisions are meant to prevent overly high-potency use. The 70-day supply limit mentioned (70 daily doses) thus depends on the daily amount prescribed by the physician.
• Packaging and Labeling: All medical cannabis products must be in child-resistant packaging and bear a universal state symbol on the label indicating it is medical cannabis^[7]. Labels also include the THC/CBD content per dose, dosing instructions, tracking information, and health warnings. Advertising is heavily restricted – products cannot be packaged or marketed with images or flavors that appeal to minors (no cartoon characters, fruit shapes, etc., similar to the hemp product restrictions)^[3]. Every item is tracked from seed to sale by the statewide tracking system^[7].

In summary, Alabama’s program provides medical patients access to cannabis-derived medicines, but in a form and manner akin to a tightly controlled pharmacy model. The focus is on measured doses, pharmaceutical preparations, and preventing any recreational or high-potency usage.

Dispensary Access and Purchases

Licensed Dispensaries: Medical cannabis may be dispensed only by state-licensed dispensaries regulated by the AMCC. Dispensaries function much like specialized pharmacies for cannabis. To legally purchase, a patient (or their caregiver) must present their medical cannabis card at an Alabama-licensed dispensary. Each purchase is logged in the Alabama Medical Cannabis Patient Registry System in real time to ensure patients do not obtain more than their allowed dosage or beyond the 70-day supply limit.

Geographic Availability: Dispensaries will be located only in jurisdictions that affirmatively allow them. The law gave counties and cities the option to “opt-in” by local ordinance or resolution. A dispensary cannot operate in a city or county that has not authorized medical cannabis dispensing within its boundaries^[10][10]. As of early 2024, numerous cities and some counties have passed ordinances permitting dispensaries (including Birmingham, Montgomery, Mobile, and others), while some areas have remained “dry” for cannabis^[10][10]. This patchwork means patients may have to travel to a neighboring jurisdiction if their hometown banned dispensaries. The AMCC maintains a list of localities that have approved dispensaries^[10].

Dispensary Operations: Under Alabama law and AMCC rules, dispensaries must follow strict operational requirements^[2][2]. Some key rules:

• Qualified Staff: Each dispensary must have a certified dispensary employee with appropriate training on duty at all times to counsel patients. The Commission’s 2022 regulations require dispensary managers (termed “certified dispensers”) to have at least a two-year degree in a relevant field (e.g., pharmacy, pharmacology, nursing, or chemistry) or comparable experience^[2]. They must also complete a course on medical cannabis use. This is to ensure patients receive knowledgeable guidance about dosing, product selection, and potential side effects.
• Security: Dispensaries must implement robust security measures. This includes 24/7 video surveillance (with at least 60 days of footage retention)^[2], alarm systems, and on-site security personnel whenever open^[2]. They must have secure vaults for storing inventory and follow chain-of-custody protocols for all product movement. Armed security guards or off-duty law enforcement are commonly required during transport and at dispensing sites.
• Inventory Tracking: All products are tracked via the state’s seed-to-sale tracking system^[7]. Dispensaries can only sell products that are logged in the system as produced by a licensed cultivator/processor and tested by a licensed lab. Each sale to a patient is recorded (patient ID, product, quantity, date/time) in the electronic tracking system, which interfaces with the patient registry to ensure dosage limits are not exceeded.
• Purchase Limits: A dispensary may only dispense up to the patient’s recommended daily dosage multiplied by the number of days until the patient’s next doctor visit or 70 days (whichever is less)^[5]. This effectively prevents stockpiling. Additionally, no single dispensing can be more than 70 daily doses. The staff must verify each purchase will not put the patient over their legal supply limit. There are also per-transaction limits on certain products (for example, the Commission might set a maximum milligrams of THC per transaction to enforce the statute).
• Out-of-State Patients: Alabama’s law currently does not recognize out-of-state medical marijuana cards. Dispensaries are forbidden from selling to any person who is not in the Alabama registry^[2]. Likewise, Alabama patients cannot use their card to buy cannabis in other states (unless that state independently allows out-of-state patients). There is no reciprocity at this time.
• On-Site Use: Consumption on the dispensary premises is not allowed. Products must leave in opaque, tamper-evident packaging. Dispensaries also cannot dispense via vending machines or drive-through windows; sales must be person-to-person with an ID check.
• Non-Patients: Only registered patients and caregivers may enter the dispensing area of a medical cannabis dispensary^[2]. Similar to a pharmacy, it is not open to the general browsing public. Visitors may need to show their registry ID to gain entry.
• Hours and Location Restrictions: The Commission, along with local ordinances, controls dispensary locations through zoning (distancing from schools, daycares, churches, etc., often required at least 1,000 feet away). Dispensaries may have limited hours (e.g., not open late night) as set by regulations or local conditions. They must prominently display their state license and comply with inspections.

Program now operational (June 2026): After roughly five years of delays and licensing litigation, Alabama’s medical cannabis program has launched. The first state-sanctioned medical cannabis sale in Alabama history took place on June 3, 2026 at Callie’s Apothecary in Montgomery (operated by dispensary licensee CCS of Alabama), which held its grand opening on June 4, 2026^[11]. Three dispensaries were open as of mid-September 2026: Callie’s Apothecary in Montgomery (June 4) and Talladega (August 28), and GP6 Wellness’s Bama Bloom in Athens (September 14), the first in North Alabama;^[12] the AMCC awarded four dispensary licenses in December 2025–January 2026 (CCS of Alabama, GP6 Wellness, RJK Holdings, and — pending litigation — Yellowhammer Medical Dispensary), and more storefronts are expected to open in fall 2026^[8]. When the program is fully built out, those companies are authorized to operate up to 12 dispensing sites statewide. Registered patients must still travel to an operating dispensary to purchase, and as of mid-May 2026 roughly 180–200 patients had registered and 43 physicians were certified to recommend cannabis as the market opened^[8]. Patients still cannot lawfully buy cannabis in other states on an Alabama card, and Alabama does not recognize out-of-state cards.

Integrated facility licenses, July 2026 hearing. The five contested integrated facility licenses remain unissued. The Alabama Medical Cannabis Commission took evidence on them on July 27, 2026 in Tuscaloosa before hearing officer Bernard Harwood, a former Alabama Supreme Court associate justice. He issues a recommended order, after which the Commission votes at a separate public meeting once the parties file exceptions^[13].

Caregivers’ Role and Rights

Under the program, a registered caregiver is an individual at least 21 years old (or 19 if the caregiver is the patient’s parent/guardian) who is authorized to assist a qualified patient with medical cannabis^[7]. Caregivers are typically used for minors or adult patients who are physically unable to travel or administer their own medication. Each caregiver must apply and be approved by the AMCC (including a background check). A caregiver can serve no more than two patients at once, unless the caregivers’ patients are immediate family, in which case a caregiver may assist up to three family members^[2] (these limits are set by rule).

Caregivers have the legal authority to transport and possess medical cannabis on behalf of their patient. For example, a parent caregiver can go to the dispensary and buy the child’s cannabis medicine, or a caregiver of a disabled adult can help administer a dose. Like patients, caregivers in compliance are protected from prosecution for possession of the patient’s medicine^[5]. They must carry their caregiver identification card when in possession of cannabis. Any misuse (such as diverting the cannabis for personal use or to others) is subject to criminal penalties and disqualifies the caregiver.

The law limits who can be a caregiver: those with certain felony convictions (especially drug offenses or violent crimes) are not eligible. Caregivers cannot be the patient’s certifying physician or an employee of a cannabis company providing product to that patient (to avoid conflicts of interest). They also cannot consume the patient’s cannabis themselves—caregivers are only legal possessors, not users.

Medical Cannabis Commission and Regulation

The Alabama Medical Cannabis Commission (AMCC) is the primary regulatory authority overseeing all aspects of the medical program (aside from physician certification, which is handled by ALBME). The AMCC’s duties include: issuing business licenses (cultivators, processors, etc.), maintaining the patient registry, developing regulations and forms, inspecting facilities, and enforcing compliance with the Act and rules (including investigating violations or diversion). The Commission is composed of appointees as defined by statute and began work in late 2021.

The AMCC has promulgated extensive administrative rules to implement the program. These cover application procedures, security requirements, product testing standards, labeling rules, etc. (Administrative rules are published under Alabama Admin Code Chapter 538-X). For example, AMCC rules require independent laboratory testing of all medical cannabis products for potency and contaminants before sale^[3]. They also establish recall procedures, inventory accounting methods, and rules for transportation of product between licensees. The Commission even set rules for advertising (strictly limited) and for revoking patient cards if abuse is detected (e.g., if a patient is arrested for diversion of their cannabis, the Commission can suspend their card).

Another agency, the Alabama Board of Medical Examiners, has its own rules (Admin Code Chapter 540-X-25) governing physician conduct in the medical cannabis program. These include the physician permitting process, required evaluation procedures (a physician must have a bona fide patient relationship and must evaluate the patient’s history and do an in-person exam before recommending cannabis^[7]), and follow-up care. Physicians must re-evaluate a patient at least annually (or more frequently as directed) to continue certifications. Failure to follow these standards can result in disciplinary action against the physician’s license.

Overall, Alabama’s medical cannabis program is characterized by its conservatism and medical focus: limited qualifying conditions, non-smokable products, tight control from seed to sale, and involvement of medical professionals at multiple levels. It is designed to function within a medical model rather than a commercial or recreational model.

Cannabis Business Regulations in Alabama

Alabama law establishes a comprehensive licensing and regulatory regime for any enterprise involved in medical cannabis. No legal cannabis commerce can occur outside this licensed system. The Alabama Medical Cannabis Commission (AMCC) is charged with reviewing applications and issuing licenses in several categories, as authorized by the Compassion Act (Ala. Code § 20-2A-50 to 20-2A-68). Below we outline the license types, the application process and requirements, operational rules for businesses, and taxation of cannabis businesses.

License Categories

Alabama offers five types of medical cannabis business licenses (plus one combined category), each with specific authorized activities^[7][7]:

• Cultivator License: Authorizes the cultivation of cannabis plants and the sale/transfer of harvested cannabis to a licensed processor^[10]. Cultivators grow cannabis in controlled facilities and may contract with a processor to process their crop into final products (in which case the cultivator can directly transfer processed medical cannabis to dispensaries)^[10]. Alabama initially allows up to 12 cultivator licensesstatewide^[10]. Annual license fee: $40,000^[10].
• Processor License: Authorizes purchasing cannabis from cultivators and manufacturing it into medical cannabis products^[10]. Processors handle extraction, refinement, formulation, and packaging of cannabis oil and infused products in the permitted forms. They then sell or transfer the finished medical cannabis products to dispensaries. Alabama caps this at 4 processor licenses statewide^[10]. Annual license fee: $40,000^[10].
• Dispensary License: Authorizes an entity to dispense and sell medical cannabis products directly to registered patients and caregivers^[10]. Dispensaries may obtain product from processors or, in some cases, directly from cultivators (if the cultivator had it processed on their behalf)^[10]. A dispensary licensee can operate up to 3 retail dispensing sites (locations) under one license^[10]. The law initially allows only 4 dispensary licenses total in the state^[10]. (This does not count dispensing by integrated facilities, discussed next.) Annual license fee: $40,000^[10].
• Secure Transporter License: Authorizes the transport and storage of cannabis and medical cannabis products between licensed facilities (e.g., from a cultivator to a processor, or processor to a dispensary)^[10]. Transporters are essentially logistics providers and may charge fees for their service. They cannot transport product to patients or caregivers, only between licensees^[10]. There is no numerical cap on transporter licenses^[10]. Annual license fee: $30,000^[10].
• State Testing Laboratory License: Authorizes a laboratory to possess and test cannabis and medical cannabis products for quality control^[10]. Labs will test for potency (THC/CBD levels) and safety (pesticides, heavy metals, microbial contamination, etc.) as required by law. Labs must be independent from other licensees (no ownership overlap). There is no cap on testing lab licenses^[10]. Annual license fee: $30,000^[10].
• Integrated Facility License: This special license type allows a company to vertically integrate, performing multiple functions under one license. An integrated facility may cultivate, process, transport, and dispense medical cannabis (essentially combining the roles of cultivator, processor, transporter, and dispensary)^[7][7]. Each integrated licensee can operate up to 5 dispensary sites of its own^[10]. Alabama law provided for up to 5 integrated facility licenses initially^[10]. Annual license fee: $50,000^[10].

The rationale for the limited numbers is to tightly control the market and avoid oversupply. The initial caps (5 integrated, 4 dispensary, 4 processor, 12 cultivator) may be adjusted by future legislation (indeed, proposals in 2024–2025 seek to increase these limits, as discussed later)^[14]. All licenses are issued by the AMCC and are valid for one year, requiring annual renewal (with renewal fees equal to the annual fee). The Commission set non-refundable application fees of $2,500 for each license application^[15].

It’s worth noting that an entity may not hold multiple different license types except via an integrated license – for example, a company cannot separately hold a cultivator and a processor license due to statutory ownership prohibitions aiming to prevent monopolistic control (one exception: a cultivator can process its own harvest through a contract processor arrangement, but not own a processor outright). The integrated license is the only vehicle to do it all, and those were also capped and competitively awarded.

Licensing Application Process and Criteria

Application Rounds: The AMCC conducts application periods during which interested companies submit detailed proposals for a license in one of the categories. The initial application window closed on December 30, 2022, for the first round of licenses^[4][2]. In that first round, the Commission received over 600 requests for applications and ultimately dozens of formal applications across the license categories^[2]. Because of the limited number of licenses (especially for dispensaries and integrated licenses), the process is highly competitive and involved a merit-based scoring of applications.

Local Approval Requirement: As part of an application, an applicant for a dispensary or integrated facility license needed to demonstrate that the proposed dispensary sites were in jurisdictions that authorized dispensing. Many local governments passed resolutions to meet this requirement (see Ala. Code § 20-2A-51)^[10][10]. Applicants had to include certified copies of those local ordinances or resolutions in their application to show compliance. This effectively required businesses to secure community buy-in before applying.

Background and Eligibility: The law and AMCC rules impose strict suitability criteria for applicants. Every owner, principal, and key employee of the applicant entity undergoes a thorough background check. Certain criminal convictions (especially any felony involving controlled substances, violence, or dishonesty) disqualify an applicant (or an individual associated with it) from licensure^[16]. All applicants must be organized under Alabama law (domestic entities) and, per Commission rule, majority ownership must be held by individuals who have been Alabama residents for a minimum period (to ensure in-state participation). Indeed, guidance indicated that proof of Alabama residency is mandatory for all individual applicants^[9]. Many applicants also partnered with medical professionals, pharmacists, or academic institutions to strengthen their credentials.

Financial Requirements: Applicants must demonstrate substantial financial stability and liquidity. State regulations required applicants to show they have at least $2 million in assets/liquid capital (this figure varied by license type; some sources indicated a $5 million liquid asset requirement for certain licenses)^[16]. They must provide detailed business plans, including startup funding, operating budgets, and proof of capital to build and sustain the operation. A hefty $50,000 surety bond is also required by the Act for each licensee, to cover potential destruction of product or other liabilities (the bond ensures funds are available for the Commission to carry out enforcement if needed).

Application Contents and Scoring: The application is extensive, often several hundred pages. Key components include:

• Business Plan – covering the organizational structure, financing, capitalization, pro forma financials, and a detailed budget. Applicants need to identify all investors and financing sources (and comply with ownership limitations).
• Operations Plan – procedures for cultivation or production (if applicable), security plans, inventory control systems, dispensing procedures, record-keeping, and staffing. Security plans must meet minimum requirements (surveillance, alarms, restricted access, transport security protocols, etc.).
• Facilities and Location – identification of property/site (with proof of ownership or lease contingent on licensing), schematic designs or floor plans, zoning compliance, and community impact. Dispensaries had to detail the layout for secure storage and patient areas.
• Experience and Expertise – information on the team’s qualifications. Many applicants partnered with out-of-state cannabis operators or industry consultants to demonstrate experience. However, the Act required that no out-of-state owner could have a majority – ensuring Alabama control. Some points were awarded for applicants who could show relevant agriculture, pharmaceutical, or medical industry experience among their principals or staff.
• Community Impact and Diversity – applicants had to include plans for community engagement, health and safety training, and diversity in hiring. While Alabama’s law does not have a specific social equity licensing program, the Commission’s scoring included factors like local job creation and representation of minority ownership.

The Commission by rule established a point-scoring system to evaluate and rank applications (often contracting with an independent evaluator for recommendations)^[17]. Only the top-ranked applicants within each category were selected for the limited slots.

License Awards and Challenges: The AMCC initially awarded licenses in June 2023, but due to identified irregularities in scoring, the Commission quickly voted to pause and rescind those awards for review^[2]. Licenses were re-awarded in August 2023 to a set of 24 companies (covering all license types)^[2]. However, multiple unsuccessful applicants filed lawsuits alleging the selection process was flawed or unfair^[14][14]. These legal challenges led to court orders in late 2023 that effectively stalled the issuance of licenses. As a result, by 2024 the program was in limbo, with a judge invalidating the latest awards and the Commission unable to move forward until the disputes are resolved^[14]. (See Recent Developments below for the legislative effort to address this impasse.)

All licensed businesses, once finalized, will be subject to ongoing oversight. Licenses can be suspended or revoked for non-compliance with rules (e.g., diversion of product, regulatory violations). The law also forbids licensees from locating near schools (minimum distance requirements apply) and requires adherence to all applicable public health standards. For instance, cultivators must comply with agricultural regulations on pesticide use; processors must adhere to sanitation and proper manufacturing practices similar to food or pharmaceutical producers.

Operational Requirements for Licensees

Once licensed, cannabis businesses in Alabama must operate under a strict regulatory framework set by statute and the AMCC rules:

• Security and Tracking: All facilities (grow sites, processing labs, dispensaries) must implement stringent security measures: perimeter fencing, 24-hour video surveillance, alarm systems, access controls, and on-site security personnel. Every movement of cannabis (plant or product) is recorded in the state seed-to-sale tracking system^[7]. Plants are tagged with unique identifiers; products are labeled with batch numbers and tracked at each stage. This system enables the AMCC to monitor inventory and detect diversion or theft. Transporters moving cannabis between sites must use secure, GPS-tracked vehicles and maintain manifests. Any theft or loss must be immediately reported to law enforcement and AMCC.
• Testing and Quality Control: Before any medical cannabis product reaches patients, it must be tested by an independent state-licensed testing laboratory^[10]. Labs test for cannabinoid potency (to ensure accurate labeling of THC/CBD content) and screen for contaminants such as pesticides, heavy metals, microbial impurities, residual solvents (in extracts), and other adulterants. Products that fail safety standards cannot be sold. The Commission sets the acceptable thresholds and can mandate recalls if a product is later found to be unsafe. Each product’s packaging will include a scannable code or batch number linking it to lab results (Certificates of Analysis).
• Packaging and Labeling: Licensees must package medical cannabis in opaque, child-resistant containers. Labels must include: the universal state cannabis symbol, the product’s THC and CBD content per dose and in total, dosing instructions, ingredient lists for processed products, the patient’s name (at dispensing), and various warnings (e.g., “For medical use only – not for resale or transfer,” “Keep out of reach of children,” and health warnings about impaired driving, etc.). Advertising by licensees is tightly controlled – basically, no mass-market advertising of cannabis products is allowed. Dispensaries cannot advertise prices or promotions that target the general public; any marketing must be subtle and not appealing to minors or non-patients.
• Employee Qualifications and Training: Key employees such as cultivation managers, extraction technicians, and dispensary pharmacists/dispensers must meet minimum qualifications set by the AMCC. All employees handling cannabis must undergo background checks and be badged by the Commission. Ongoing training in security, safety, and ethics is required. There are also restrictions to prevent conflicts of interest (e.g., lab licensees cannot have financial interest in a cultivator or processor, to ensure testing independence).
• Record-Keeping and Reporting: Licensees must maintain comprehensive records of all operations, including production volumes, inventory, sales, waste disposal, and transportation logs. Regular reports must be submitted to the AMCC. Dispensaries, for instance, must report the amount of each product sold, the patient ID, and the recommending physician for each transaction (all of which is typically automated via the state tracking system). Cultivators track each harvest batch weight; processors record yields and loss. Any incident such as security breaches or product contamination must be reported to the Commission promptly. The Commission and law enforcement have the right to inspect premises and records at any time.
• Product Restrictions: Cultivators can only grow cannabis strains approved or registered with the state (and must start from secure seeds or plant material – initial genetics often imported through DEA approval or from other legal states). The law sets a THC limit of 0.5% for any cannabis waste or byproduct leaving a facility (to prevent psychoactive material from being diverted). Processors cannot produce any unauthorized product form (e.g., no candy edibles or high-sugar products). They also cannot use certain additives (e.g., no vitamin E acetate in inhaler oils, no flavors that mimic candy or fruit aimed at children). If making gelatinous cubes/lozenges, those must be in geometrical shapes only (per the Act’s peculiar requirement).
• Fees and Renewals: Licensees must pay annual renewal fees (equal to the initial license fee). In addition, the law imposes an annual business privilege tax on medical cannabis licensees, calculated similarly to the standard Alabama business privilege tax on net worth (rates ranging from $0.25 to $1.75 per $1,000 of Alabama net worth, with a minimum tax of $100 and capped at $15,000)^[18][18]. This is in addition to any normal state corporate taxes. The proceeds of this privilege tax are allocated to the Alabama Medical Cannabis Commission Fund to support the program^[18].
• Inspections and Enforcement: The AMCC and other state agencies (Department of Agriculture for cultivation, Department of Public Health for processing sanitation, etc.) have inspection authority. Violations of regulations can result in fines, suspension, or revocation of licenses. For example, selling to an unauthorized person, exceeding plant count limits, or failing to maintain security could trigger disciplinary action. The Commission can also refer egregious violations for criminal prosecution (e.g., evidence of intentional diversion of product to the black market would likely result in arrests under trafficking laws in addition to license revocation).

Overall, Alabama’s operational rules for cannabis businesses reflect a highly controlled industry with close oversight at every step. The aim is to ensure medical cannabis is produced and dispensed safely, securely, and only to intended patients, without leakage into illicit channels.

Taxation and Revenue

Although medical cannabis is often considered “medicine,” Alabama does tax its sale. Under the Compassion Act, retail sales of medical cannabis are subject to a special 9% gross proceeds tax (effectively an excise tax on top of any normal sales taxes)^[15]. This 9% tax is levied on the gross sales price of medical cannabis at the point of retail (dispensaries). Revenue from this tax is earmarked: a significant portion goes into the state’s General Fund, and some is directed to the Medical Cannabis Commission Fund and other specific uses (such as research or law enforcement training, as outlined in the Act’s revenue distribution provisions).

In addition, as mentioned, cannabis businesses pay the annual Medical Cannabis Business Privilege Tax (capped at $15,000 per year) just for the privilege of operating^[18]. They also pay application and license fees which the AMCC uses to fund its operations. For instance, in the first year, an integrated facility might have paid $2,500 to apply and $50,000 for the license fee, aside from any local business license taxes.

Standard state and local sales taxes (which are around 4% state + local add-ons for general goods) do not apply to medical cannabis because the 9% excise is in lieu of sales tax (the law treats the cannabis similarly to prescription drugs for sales tax exemption, but then adds the specific 9% tax). Patients thus pay a 9% tax on purchases^[15]; however, this being a medicine they cannot get insurance to cover, some have argued the tax is a burden on patients. Nevertheless, Alabama included it to ensure the program is self-funding and contributes to the state budget.

Notably, the new hemp product law (HB 445 of 2023/2025) also instituted a 10% excise tax on hemp-derived THC products^[3], which parallels the medical cannabis tax. This was likely done to eliminate the incentive for consumers to use loosely-regulated Delta-8/Delta-10 products over the strictly-regulated medical products.

One more revenue aspect: the Act imposes fees on physicians for their certification permits and requires patients to pay a fee for their medical cannabis card (to offset the cost of the registry system). Physicians pay an initial permit fee and renewal fee to ALBME, and must carry malpractice insurance coverage to include medical cannabis recommendations. Patients likely pay a modest annual card fee (often in other states this is $50 or so; Alabama’s exact fee is set by rule).

Tax compliance is enforced by the Alabama Department of Revenue in coordination with AMCC. Dispensaries will remit the 9% tax similar to how they would other state excise taxes. Failure to timely pay taxes can result in penalties or jeopardize the license.

Tribal and Sovereign Territory Cannabis Laws in Alabama

Alabama is home to one federally recognized Native American tribe, the Poarch Band of Creek Indians, and several state-recognized tribes. As of 2025, there is no separate tribal cannabis program or law in effect in Alabama’s Indian country. The Poarch Band of Creek Indians (PCI) operates sovereign lands in Alabama (primarily in Escambia, Elmore, and Montgomery counties, where they have gaming facilities), but they have not legalized cannabis on their reservation. In fact, cannabis remains generally prohibited on Poarch Creek tribal land in line with state and federal law.

The intersection of tribal sovereignty and cannabis is complex. In 2014, the U.S. Department of Justice announced that federally recognized tribes may choose to legalize and regulate cannabis on their reservations (similar to states doing so) without federal interference, provided they maintain strict controls (this was often referred to as the “Cole Memorandum for Indian Country”)^[19][19]. However, that policy primarily benefits tribes in states that have legalized cannabis. In a state like Alabama, which outlaws cannabis, any tribal move to allow marijuana would be highly controversial and legally uncertain. One key DOJ enforcement factor is preventing “diversion” from a legal area to surrounding illegal areas^[19] – a tribe in Alabama growing or selling marijuana would almost certainly lead to diversion off reservation, violating that factor. Thus, DOJ guidance suggests tribes in fully prohibitionist states face a “highly uncertain” situation and would need extremely robust safeguards to avoid federal enforcement^[19][19].

The Poarch Band has not publicly pursued medical or recreational marijuana enterprises on its lands so far. In fact, Alabama state officials have been involved in litigation with the Poarch Band on other issues (notably gaming machines and sovereignty questions), and it has been speculated that if PCI’s sovereignty is affirmed in certain ways, they might have more latitude to explore industries like cannabis^[20]. One opinion piece in 2014 mused that an ongoing Alabama lawsuit against Poarch could inadvertently “determine whether the Poarch enter the marijuana industry”^[20]. To date, however, no such tribal cannabis initiative has materialized. The Poarch Band remains focused on its gaming operations and other economic ventures (hotels, agriculture, etc.), and has even stated that any rumors of opening a “marijuana shop” were just political posturing in gaming negotiations, not genuine plansnorthescambia.comnorthescambia.com.

In practical terms, a Poarch Creek tribal member is subject to tribal and federal law on reservation and Alabama law off reservation. Since tribal law has not legalized marijuana, tribe members must follow the same rules as other Alabama residents. If a tribal member qualifies as an Alabama medical cannabis patient, they would be protected under state law for possession, but they still could not legally obtain or use cannabis on tribal trust land unless the tribe permits it. The PCI has not established any medical cannabis ordinances, and their public safety officials (who often are cross-deputized with state law enforcement) would enforce prohibition on reservation lands.

It’s also worth noting that tribal sovereignty does not allow open defiance of federal drug laws; it simply means the tribe could, like a state, choose to regulate and not have federal enforcement priority, but the federal law (CSA) still nominally applies. The Poarch Band, being in a conservative state and engaged in sensitive negotiations over gaming compacts, likely has little appetite to provoke conflict by unilaterally legalizing cannabis.

In summary, there are no separate tribal cannabis laws in Alabama at this time. The only governing laws are federal (which ban cannabis) and state (which ban recreational use and allow only the narrow medical program). Any cannabis activity on tribal lands would have to comply with Alabama’s medical cannabis regulations or face the same penalties as elsewhere. The Poarch Band of Creek Indians has not established a cannabis program, and any future interest would require navigating federal policy and almost certainly consultation or agreements with the state. For now, cannabis remains off-limits in Alabama’s sovereign Native territories just as in the rest of the state^[20][20].

Recent Legislative and Regulatory Changes (2023–2026)

The period of 2023–2025 has been dynamic for Alabama’s cannabis landscape, with significant legislative tweaks and ongoing efforts to get the medical program off the ground. Below are the key recent developments:

Implementation of the Medical Cannabis Program

Although the medical cannabis law passed in 2021, actual implementation has been slow. The Alabama Medical Cannabis Commission spent 2022 developing regulations and accepting license applications^[2][2]. In June 2023, the AMCC made headlines by announcing the first-ever issuance of cannabis business licenses – selecting several companies for each category (a total of 21 licenses initially across cultivators, processors, dispensaries, etc.)^[21]. However, almost immediately, the process encountered problems. Allegations of scoring inconsistencies and possible computational errors led the Commission to nullify those awards days later, essentially restarting the final phase of selection^[2].

The AMCC regrouped and, on August 10, 2023, awarded a revised set of licenses to 24 businesses^[2]. These winners included 5 integrated facility licenses, 4 dispensaries, 4 processors, 7 cultivators (one fewer than the cap, possibly due to insufficient qualified applicants), and several transport and lab licenses^[21]. The “final” awards in August largely went to the same entities that had been named in June^[2], suggesting the re-evaluation did not drastically change outcomes. The selected companies were given 14 days to pay their license fees and begin the process of building out facilities^[2]. Conversely, rejected applicants had 14 days to file appeals with the Commission.

Subsequently, a wave of lawsuits was filed by multiple unsuccessful applicants, claiming the Commission’s process was arbitrary or unlawful. Throughout late 2023, these suits resulted in court orders pausing the issuance of licenses. In one case, a Montgomery Circuit Court judge issued an injunction invalidating the August licenses on grounds that the AMCC may have violated the Open Meetings Act or other procedural statutes during its deliberations^[22][21]. The litigation was complex, involving multiple judges and stretching the program’s rollout to roughly five years. The impasse ultimately broke in 2025: cultivators and processors began operating, and on December 11, 2025 the AMCC approved dispensary licenses (issuing three on January 8, 2026, with a fourth, Yellowhammer Medical Dispensary, still subject to ongoing litigation)^[23]. With licenses in hand, growers harvested and processors produced the state’s first approved products in spring 2026, leading to the first legal sales in June 2026 (see the Medical Cannabis Program section above). A handful of license disputes remain in litigation, but they no longer block the program from operating.

Frustration with these delays led to new legislative proposals in 2024 and 2025. Notably, in February 2025, Senate Bill 72 (SB 72) was introduced by Senator Tim Melson (one of the original sponsors of the 2021 Act) to break the logjam^[14][14]. SB 72 as introduced would make any circuit court action blocking an AMCC license decision immediately appealable to the Alabama Supreme Court, effectively bypassing lengthy trials^[14]. It also sought to expand the number of integrated facility licenses from 5 to 7 (recognizing demand) and to mandate the hiring of an independent third-party consultant to re-run the scoring and pick those seven integrated license winners from the original applicant pool by early 2026^[14]. This bill aimed to expedite the resolution of lawsuits and get the industry started by removing some judicial bottlenecks. SB 72 was debated in the 2025 session, with some questioning its constitutionality (particularly the court-jumping provision)^[14]. The AMCC has publicly stated it supports measures to speed up availability of medical cannabis for patients^[14]. Regardless of SB 72’s fate, the licensing impasse was ultimately resolved through the courts and AMCC action, and dispensary licenses were awarded in December 2025, allowing the program to launch in 2026 (see above).

Another bill in 2024 (by Sen. David Sessions) proposed to increase the number of dispensary licenses from 4 to 7 and adjust some program timelines^[24][14], reflecting recognition that the initial caps might have been too low to serve the state’s population. These proposals indicate a legislative willingness to tweak the 2021 law as needed.

In terms of regulatory changes, the AMCC and the Alabama Board of Medical Examiners continued refining rules. In late 2022 and 2023, ALBME finalized its rules for physician certification, as mentioned (requiring an exam, setting conditions for recommendations, etc.). The AMCC also adopted various substantive rules in 2022 for license operations, and in 2023 it tackled issues like packaging standards and recall procedures through its rulemaking authority. One example of evolving regulation: the Commission clarified dosing guidelines for certain conditions and adjusted training requirements for dispensary staff, via amendments to the administrative code in 2023 (these were technical and aimed at smoothing implementation).

Hemp-Derived THC Regulation (HB 445)

A major legislative action in 2023 was Alabama’s response to the proliferation of hemp-derived THC products (like Delta-8 gummies and vapes being sold in gas stations, head shops, etc.). House Bill 445, sponsored by Rep. Andy Whitt, was passed by the legislature and signed by Governor Kay Ivey. This law is effectively Alabama’s Hemp Product Regulation Act, and it took effect July 1, 2023, with phased enforcement (full enforcement by January 1, 2026)^[3].

Key provisions of HB 445 include:

• Placing all consumable hemp-derived cannabinoids under the regulatory authority of the Alabama ABC Board (the agency that regulates alcohol)^[3].
• Licensing of sellers: Any retail store wishing to sell hemp products with psychoactive cannabinoids must obtain an ABC license (annual fee $1,000) and have owners pass background checks^[3][3].
• Banning smokable and inhalable hemp products: This means no hemp flower, pre-rolled hemp joints, or vape cartridges containing Delta-8, Delta-10, etc., can be sold legally^[3][3]. It also bans synthetic cannabinoids outright (lab-created THC analogues).
• Only edibles and beverages infused with hemp-derived cannabinoids are permitted, and these must be limited to 10 mg of THC per serving, 50 mg per package^[3][3]. This THC can be delta-8, delta-9 from hemp, or others, but the total per serving is capped.
• Imposing age restrictions: buyers must be 21 or older for any hemp THC product^[3].
• Strict packaging and marketing rules mirroring those for medical cannabis: child-resistant packaging, no cartoons or youth-oriented branding on labels^[3].
• Mandatory lab testing of hemp products and readily available Certificates of Analysis to verify content and purity^[3].
• Creating a new 10% excise tax on retail sales of hemp THC products, with revenue split 90% to the state General Fund and 10% to local governments^[3].
• Establishing penalties for violations: selling without a license or selling banned products can result in fines and criminal charges (a misdemeanor or possibly a Class D felony for repeat offenders or large quantities, as per existing Alabama Code provisions on adulterated foods or drugs).

This law was a response to concerns that unregulated Delta-8 products (which have intoxicating effects similar to marijuana) were undermining the state’s drug laws and potentially endangering consumers (as their potency and purity were untested). The delayed full enforcement date (2026) is giving existing businesses time to comply or sell through inventory, but as of mid-2025 the ABC Board has begun rulemaking and licensing for hemp product sellers. Enforcement action has included warning letters and some raids on shops selling non-compliant vapes even before 2026.

Impact: HB 445 effectively shuts the door on a “grey market” that existed post-2018 Farm Bill, where people could legally buy Delta-8 THC cartridges or hemp flower in Alabama. Now, those products are illegal, steering any legitimate medical use strictly into the formal medical cannabis program. It also means individuals who possessed what they thought was “legal hemp” could now be holding contraband if it’s a banned form (for instance, hemp bud is now treated like marijuana). The state’s stance is that intoxicating THC, regardless of source, should be regulated comparably.

Medical Program Updates

Beyond the licensing and hemp law, Alabama saw smaller updates:

• Qualifying Conditions Expansion: There have been discussions about adding conditions to the medical program. For example, in 2023 some patient advocates pushed to add conditions like opioid use disorder or more generalized anxiety disorders. However, as of 2025, no new conditions have been officially added beyond the original list in the 2021 Act^[7][7]. The law allows the AMCC to recommend additions to the Legislature, but Alabama has proceeded cautiously. Any expansion likely needs legislative approval unless one interprets the law to allow the Commission or the State Board of Medical Examiners to approve by rule – but they have not done so yet.
• Medical Research Program: The Compassion Act created the Alabama Medical Cannabis Research Fund and provided for research licenses for universities (§ 20-2A-100 et seq.). In late 2023, the state announced initial steps to fund research on medical cannabis efficacy for certain conditions (e.g., UAB exploring cannabis for pain management). Grant processes are being set up to use a portion of tax revenue to sponsor clinical research in Alabama.
• Public Education Campaigns: In 2024, the AMCC, in conjunction with the Department of Public Health, launched educational materials for the public and law enforcement about the new medical cannabis law. This includes guidance to police on recognizing valid medical cannabis cards and packaging, as well as information to healthcare providers about how the program works. The goal is to ensure smooth integration once products hit the market.
• Board of Medical Examiners Rule (2023): As mentioned, ALBME issued final rules (Rule 540-X-25-.03, .04, etc.) requiring that no physician may certify more than a certain number of patients for cannabis at one time (to prevent “pill-mill” like scenarios). They also require physicians to re-evaluate cannabis patients at least quarterly in the first year. These rules were updated in 2023 to clarify telehealth restrictions – initial certification must be in person, but some follow-ups can be via telemedicine, per ALBME guidance. The intent is tight medical oversight.

Criminal Law and Enforcement Trends

On the criminal law front, while the statutes have not significantly changed (aside from the hemp product law), the enforcement climate has seen some shifts:

• Marijuana Arrests: Arrest data show that Alabama continues to arrest thousands of people annually for marijuana, although there was a dip in 2020–2021 (likely due to pandemic-related policing changes and data collection issues) followed by a rebound. FBI crime data compiled by NORML indicate Alabama had approximately 6,900 marijuana possession arrests in 2023 (accounting for about 43% of all drug possession arrests in the state that year)^[25]. This was a slight decrease from roughly 7,660 possession arrests in 2022^[25]. The trend suggests enforcement remains vigorous; Alabama was among the top ten states for total marijuana arrests per capita. The number of arrests for marijuana sales/manufacture was much lower (190 in 2023)^[25], reflecting that most law enforcement activity targets simple possession.
• Racial Disparities: The issue of racial disparity in marijuana enforcement has gained attention. A landmark 2018 report by Alabama Appleseed and the Southern Poverty Law Center found Black individuals were 4 times more likely than white individuals to be arrested for marijuana possession in Alabama, despite similar usage rates^[26]. In some jurisdictions, the disparity was over 10:1^[26]. Recent data suggest these disparities persist. Civil rights groups continue to advocate for decriminalization or at least for law enforcement to deprioritize low-level possession, given these inequities and the heavy human and fiscal costs (the 2018 study estimated over $22 million spent annually enforcing marijuana possession laws)^[26]. While the laws have not changed, some larger cities have taken modest steps (e.g., the Mayor of Birmingham in 2021 issued pardons for thousands of past minor marijuana convictions, and the City of Mobile’s police indicated a shift toward citation in lieu of arrest for first-time possession). These local efforts, however, don’t negate state law; they are discretionary policies.
• Pending Decriminalization Bills: Every year in recent memory, legislators have introduced bills to decriminalize small amounts of marijuana. For instance, SB 160 (2022) would have made possession of under 2 ounces a violation punishable only by a fine (no jail) and enabled expungement of such offenses^[2][2]. That bill was indefinitely postponed in committee. In 2023 and 2024, similar bills were introduced but did not gain traction in the Republican-dominated legislature. The medical cannabis success in 2021 has not yet translated into broader reform for recreational users. As of 2025, simple possession remains a misdemeanor with possible jail time, but there is a growing bipartisan acknowledgment that incarcerating individuals for personal-use amounts is not the best use of resources. Whether that leads to actual legal change in upcoming sessions remains uncertain.
• Federal Law and Task Forces: Federal law (the Controlled Substances Act) still prohibits marijuana use, but federal agencies largely defer to states on intrastate medical cannabis. Alabama does not have legal adult-use, so any large trafficking cases tend to be picked up by federal task forces. In 2023–2024, several significant busts of interstate marijuana trafficking rings were made in Alabama, often involving shipments from western states. The U.S. Attorney’s Offices in Alabama have pursued these large cases (particularly those with hundreds of pounds of cannabis or involving other drugs and guns). However, federal enforcement against individual medical users is virtually nonexistent. The federal-state tension has historically been most pronounced in banking and finance: Alabama cannabis businesses have faced the same challenges with banking and IRS §280E tax treatment as operators nationwide. That §280E burden eased in 2026: on April 22, 2026 the DOJ/DEA issued a final order moving state-licensed medical marijuana and FDA-approved marijuana products from Schedule I to Schedule III, published and effective April 28, 2026^[27]. Schedule III status lets state-legal medical operators (such as Alabama’s licensees) deduct ordinary business expenses on their federal taxes — the main practical effect — and broadens researcher access to state-legal product; adult-use/recreational cannabis remains Schedule I, and the change does not legalize anything new at the state level^[28]. A broader DEA rescheduling hearing concluded on July 15, 2026. In Alabama specifically, the state did not automatically follow the federal move: on May 21, 2026 the Alabama Department of Public Health’s State Committee of Public Health voted to object to automatically rescheduling marijuana under state law, triggering a 30–60 day public-comment period so officials could study the implications. State Health Officer Dr. Scott Harris stressed Alabama “fully intends” to implement the change, and the AMCC said it foresees no immediate impact on the medical program either way^[29]. In short, the federal change is medical-only and chiefly a tax/research matter; it does not alter Alabama’s possession penalties, product limits, dosing caps, taxes, or licensing.

Looking Ahead

By 2026, Alabama has not only established the framework of a restrictive medical cannabis program and taken action against unregulated THC products — it has finally brought the program online. Licensed cultivators and processors began producing approved products in spring 2026, the first dispensary (Callie’s Apothecary in Montgomery) opened, and the first legal medical cannabis sales in Alabama history took place on June 3, 2026, nearly five years after the 2021 Act^[11]. Second and third dispensaries opened in Talladega on August 28 and Athens on September 14, 2026, with more expected that fall.^[12] The state will now be watching closely the outcomes in terms of patient health, revenues generated, and any societal effects.

No recreational legalization appears imminent in Alabama’s near future. The political climate favors a cautious, medical-only approach. However, adjacent states (like Mississippi and Florida) have medical programs, and public opinion is slowly shifting. Any change will likely come incrementally – perhaps decriminalizing possession first, or expanding medical access – rather than a swift move to full legalization.

In conclusion, Alabama’s cannabis laws as of 2025 reflect a compromise between compassion for certain patients and a continued commitment to drug prohibition for the general populace. The legal reference points – from the Alabama Code sections on controlled substances and the Compassion Act, to the new administrative rules and enforcement statistics – all underscore that Alabama’s approach to cannabis remains one of careful control, medicalization, and strict penalties outside the narrow legal parameters^[1][1].

Sources: Alabama Code Title 13A (Criminal Code) and Title 20, Chapter 2A (Compassion Act); Alabama Administrative Code (AMCC and ALBME rules); Alabama Medical Cannabis Commission publications; Alabama Appleseed/SPLC report; 2023–2025 legislative records and news coverage^[1][5].